In vitro antifungal activity of ZJ-522, a new triazole restructured from fluconazole and butenafine, against clinically important fungi in comparison with fluconazole and butenafine

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 8, 2005, Pages 1414-1417

  Gao, Ping Hui ^a   Cao, Yong Bing ^a   Xu, Zheng ^a   Zhang, Jun Dong ^a   Zhang, Wan Nian ^a   Wang, Yan ^a   Gu, Jun ^b   Cao, Ying Ying ^a   Li, Ruo Yu ^c   Jia, Xin Ming ^a   Jiang, Yuan Ying ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Antifungal activity; Butenafine; Fluconazole; MIC; ZJ 522

Indexed keywords

ANTIFUNGAL AGENT; BUTENAFINE; FLUCONAZOLE; OXIDOREDUCTASE INHIBITOR; SQUALENE MONOOXYGENASE; STEROL 14ALPHA DEMETHYLASE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; ZJ 522;

ANTIFUNGAL ACTIVITY; ARTICLE; CHEMICAL MODIFICATION; CLINICAL LABORATORY; CONTROLLED STUDY; DILUTION; DRUG DETERMINATION; DRUG POTENCY; DRUG STRUCTURE; FUNGAL STRAIN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STANDARD; YEAST;

ANTIFUNGAL AGENTS; BENZYLAMINES; FLUCONAZOLE; FUNGI; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; TRIAZOLES;

EID: 25644452620     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.1414     Document Type: Article

References (25)

1. Banerjee S. N., Emori T. G., Culver D. H., Gaynes R. P., Jarvis W. R., Horan T., Edwards J. R., Tolson J., Henderson T., Marton W. J., Am. J. Med., 91 (Suppl. 3B), 86S-89S (1991).
2. Denning D. W., Curr. Opin. Infect. Dis., 7, 456-462 (1994).
3. Morrison V. A., Haake R. J., Weisdorf D. J., Am. J. Med., 96, 497-503 (1994).
4. Samaranayake L. P., Holmstrup P., J. Oral Pathol. Med., 18, 554-564 (1989).
5. Banerjee S. N., Emori T. G., Culver D. H., Gaynes R. P., Jarris W. R., Horan T., Am. J. Med., 91, 86S-89S (1991).
6. Beck-Sague C. M., Jarvis T. R., J. Infect. Dis., 167, 1247-1251 (1993).
7. Pfaller M. A., Messer S. A., Hollis R. J., Jones R. N., Doern G. V., Brandt M. E., Hajjeh R. A., Diagn. Microbiol. Infect. Dis., 33, 217-222 (1999).
8. Barchiesi F., Tortorano A. M., Falconi Di Francesco L., Cogliati M., Scalise G., Viriani M. A., J. Antimicrob. Chemother., 43, 295-299 (1999).
9. Nguyen M. H., Peacock J. E., Morris A. J., Tanner D. C., Nguyen M. L., Snydman D. R., Wagener M. M., Rinaldi M. G., Yu V. L., Am. J. Med., 100, 617-623 (1996).
10. Latgé J. P., Clin. Microbiol. Rev., 12, 310-350 (1999).
11. Mitchell T. G., Perfect J. R., Clin. Microbiol. Rev., 8, 515-548 (1995).
12. Andriole V. T., J. Antimicrob. Chemother., 44, 151-162 (1999).
13. Hoffman H. L., Ernst E. J., Klepser M. E., Expert Opin. Investig. Drugs Rev., 9, 593-605 (2000).
14. Rex J. H., Rinaldi M. G., Pfaller M. A., Agents Chemother., 39, 1-8 (1995).
15. Aoun M., Rev. Med. Brux. Jun; Rev., 25, 166-171 (2004).
16. Makimura K., Sudo T., Kudo M., Uchida K., Yamaguchi H., Microbiol. Immunol., 42, 55-59 (1998).
17. Morrow J. D., Am. J. Med. Sci. Rev., 302, 129-132 (1991).
18. Iwatani W., Arika T., Yamaguchi H., Antimicrob. Agents Chemother., 37, 785-788 (1993).
19. McNeely W., Spencer C. M., Drugs Rev., 55, 405-412 (1998).
20. Zhang W. N., Ji H. T., Zhou Y. J., Lv J. G., Zhu J., Liu X. L., Zhang L., Zhu J., China patent 1 292 378 (2003).
21. National Committee for Clinical Laboratory Standards, Reference method for broth dilution antifungal susceptibility testing of yeasts. Tentative standard M27-T. National Committee for Clinical Laboratory Standards, Wayne, Pa., 1995.
22. National Committee for Clinical Laboratory Standards, Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa., 1997.
23. Yamaguchi H., Uchida K., Kume H., Shinoda T., Watanabe K., Kusunoki T., Hiruma M., Ishizaki H., Jpn. J. Med. Mycol., 36, 61-86 (1995).
24. National Committee for Clinical Laboratory Standards, Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed standard M38-P. National Committee for Clinical Laboratory Standards, Wayne, Pa., 1998.
25. Graybill J. R., Clin. Infect. Dis. Rev., 22 (Suppl. 2), S166-178 (1996).